4.17 BIBLIOGRAPHY: 
1. Berd, D., Maguire, H.C., Jr., Mastrangelo, M.J. Induction of cell-mediated 
immunity to autologous melanoma cells and regression of metastases after 
treatment with a melanoma cell vaccine preceded by cyclophosphamide. 
Cancer Res. 1986; 46: 2572-2577. 
2. McCune, C.S., Schapira, D.V., Henshaw, E.C. Specific immunotherapy of 
advanced renal carcinoma: Evidence for the polyclonality of metastases. 
Cancer 1981; 47: 1984-1987. 
3. Neidhart, J.A., Murphy, S.G., Hennick, L.A., Wise, H.A. Active specific 
immunotherapy of stage IV renal carcinoma with aggregated tumor antigen 
adjuvant. Cancer 1980; 46: 1128-1134. 
4. Hoover, H.C., Jr., Surdyke, M.G., Dange! ; R.B., Peters, L.C., Hanna, M., Jr. 
Prospectively randomized trial of adjuvant active-specific immunotherapy for 
human colorectal cancer. Cancer 1985; 55: 1236-1243. 
5. Mitchell, M.S., Harel, W., Kempf, R.A., Hu, E., Kan-Mitchell, J., Dean, G., 
Moore, J. Active specific immunotherapy for melanoma. J. Clin. Oncol. 
1990, 8: 1-13. 
6. Seigler, H.F., Cox, E., Mutzner, F., Shepherd, L., Nicholson, E., Shingleton, 
W.W. Specific active immunotherapy for melanoma. Ann. Surg. 1979, 190: 
366-372. 
7. Cox, E.B., Vollmer, R., Seigler, H.F. Melanoma in the Southeastern United 
States: Experience at the Duke Medical Center, in Cutaneous Melanoma: 
Clinical Managemenet and Treatment REsults Wourldwide : (Eds.) Balch, 
C.M., Milton, G.W., Shaw, H.M., Soong, S.J. 1985, pp. 407-418. 
8. Wallack, M., Bash, J., Leftheriotis, E., Seigler, H.F., Bland, I., Waneobo, H., 
Balch, C. Positivge relationship of clinical and serological responses to 
vaccinia melanoma oncolysate. Arch. Surg., 1987, 122: 1460-1463. 
9. Darrow, T.L., Slingluff, C.L., Seigler, H.F. The role of HLA Class I antigens 
in recognition of melanoma cells by tumor-specific cytotoxic T-lymphocytes: 
Evidence for shared tumor antigens. J Immuno., 1989, 142(9): 3329-3335. 
10. Slingluff, C.L., Darrow, T.L., Seigler, H.F. Melanoma-specific cytotoxic T- 
cells generated from peripheral blood lymphocytes: Implications of a 
renewable source of precursors for adoptive cellular immunotherapy. Ann. 
Surg., 1989, 210(2): 194-202. 
1 1. Crowley, N.J., Vervaert, C.E., Seigler, H.F. Treatment of human melanoma 
[646] 
Recombinant DNA Research, Volume 17 
